Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Kidney International Reports|April 18, 2023
Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular DiseaseYelena Drexler, Judith Molina, Tali Elfassy, et al.
Journal of Molecular Biology|July 28, 2012
A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibodyEverardo Remi Rodríguez-Rodríguez, Luis M Ledezma-Candanoza, Luis Gabriel Contreras-Ferrat, et al.
Frontiers in Immunology|May 9, 2012
Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationSarah Bruneau, Craig Bryan Woda, Kevin Patrick Daly, et al.
Archives of Internal Medicine|July 19, 2002
Successful blood pressure control in the African American Study of Kidney Disease and HypertensionJackson T Wright, Lawrence Agodoa, Gabriel Contreras, et al.
Seminars in Dialysis|December 8, 2006
Utility of static pressure ratio recording during angioplasty of arteriovenous graft stenosisArif Asif, Anatole Besarab, Florin Gadalean, et al.
Urology Case Reports|June 11, 2025
Successful living donor kidney transplantation following ex vivo repair of renal artery aneurysmDaniel Alejandro Arreola-Ramírez, Sahara Hurtado-Gómez, Alec Anceno, et al.
Clinical Nephrology|December 15, 2022
One-year all-cause mortality in hospitalized patients with COVID-19 and end-stage renal disease undergoing hemodialysisJair Munoz Mendoza, Laura Aponte-Becerra, Carlos Torres, et al.
Hypertension (Dallas, Tex. : 1979)|October 31, 2007
Prevalence and correlates of left ventricular hypertrophy in the African American Study of Kidney Disease Cohort StudyGail E Peterson, Tine de Backer, Avril Gabriel, et al.
Rheumatology (Oxford, England)|November 26, 2009
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyDavid Isenberg, Gerald B Appel, Gabriel Contreras, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2022
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN StudyRichard Furie, Brad H Rovin, Frédéric Houssiau, et al.
Pageof 9